Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 4
Submit an article Journal homepage
717
Views
0
CrossRef citations to date
0
Altmetric
Short Report

Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study

Akiko Tozawa-Onoa Department of Gynecology, St. Marianna University School of Medicine, Toyoko Hospital, Kanagawa, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7057-980X
ORCID Icon,
Masaharu Kamadab Department of Obstetrics and Gynecology, Mutual Aid Association of Public School Teachers, Shikoku Central Hospital, Shikokuchuo, Japan
,
Katsuhiro Teramotoc Yamanashi Koseiren Health Care Center, Yamanashi, Japan
,
Hitoshi Hareyamad Sapporo Maternity Women’s JR-Tower Clinic, Hokkaido, Japan
,
Shoji Kodamae Division of Gynecology, Niigata Minami Hospital
,
Tokuzo Kasaif Chiba Foundation for Health Promotion& Disease Prevention, Chiba, Japan
,
Osamu Iwanarig Department of Obstetrics and Gynecology, Shimane Prefectural Central Hospital, Izumo, Shimane, Japan
,
Tomoe Koizumih Dokkyo Medical University Saitama Medical Center: Koshigaya, Saitama, Japan
,
Nobuyoshi Ozawai Ozawa Women’s General Clinic, Miyagi, Japan
,
Mitsuaki Suzukij Cancer Center, Shin-Yurigaoka General Hospital, Kanagawa, Japan
&
Katsuyuki Kinoshitak Seijyo Kinoshita Hospital, Tokyo, Japan
 show all
Pages 950-954 | Received 05 Jun 2020, Accepted 26 Aug 2020, Published online: 29 Oct 2020

References

  • Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumors of female reproductive organs. Lyon, France: International Agency for Reserch on Cancer; 2014.
  • Inoue M, Sakaguchi J, Sasagawa T, Tango M. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer. 2006;16(3):1007–13. doi:10.1111/j.1525-1438.2006.00460.x. PMID: 16803477.
  • Manini I, Montomoli E. Epidemiology and prevention of human Papillomavirus. Annali di igiene: medicina preventiva e di comunita. 2018;30(4Supple 1):28–32. doi:10.7416/ai.2018.2231. PMID: 30062377.
  • Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. J Infect Dis. 2007;196(10):1438–46. doi:10.1086/522864. FUTURE II Study Group. PMID: 18008221.
  • Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301–14. doi:10.1016/S0140-6736(09)61248-4. PMID: 19586656.
  • Crowe E, Pandeya N, Brotherton JM, Dobson AJ, Kisely S, Lambert SB, Whiteman DC. Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia. BMJ. 2014;348:g1458. doi:10.1136/bmj.g1458. PMID: 24594809.
  • Baldur-Felskov B, Dehlendorff C, Munk C, Kjaer SK. Early impact of human papillomavirus vaccination on cervical neoplasia–nationwide follow-up of young Danish women. J Natl Cancer Inst. 2014;106(3):djt460. doi:10.1093/jnci/djt460.
  • Pollock KG, Kavanagh K, Potts A, Love J, Cuschieri K, Cubie H, Robertson C, Cruickshank M, Palmer TJ, Nicoll S. Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland. Br J Cancer. 2014;111(9):1824–30. doi:10.1093/jnci/djt460. PMID: 24552678.
  • Petry KU, Bollaerts K, Bonanni P, Stanley M, Drury R, Joura E, Kjaer SK, Meijer CJLM, Riethmuller D, Soubeyrand B, et al. Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine. Hum Vaccin Immunother. 2018;14(7):1800–06. doi:10.1080/21645515.2018.1450125. PMID: 29553886.
  • Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res (Amsterdam, Netherlands). 2018;5:96–103. doi:10.1016/j.pvr.2018.02.002. PMID: 29481964.
  • Yamaguchi M, Sekine M, Kudo R, Adachi S, Ueda Y, Miyagi E, Hara M, Hanley SJB, Enomoto T. Differential misclassification between self-reported status and official HPV vaccination records in Japan: implications for evaluating vaccine safety and effectiveness. Papillomavirus Res (Amsterdam, Netherlands). 2018;6:6–10. doi:10.1016/j.pvr.2018.05.002. PMID: 29807210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.